The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 28 (2) , 166-176
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Outcome after Reduced Chemotherapy for Intermediate-Risk NeuroblastomaNew England Journal of Medicine, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COGPediatric Blood & Cancer, 2009
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeBritish Journal of Cancer, 2009
- Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group DatabaseJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A geneBMC Genomics, 2008
- Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genesGenes, Chromosomes and Cancer, 2008
- In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal originOncogene, 2007
- Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplificationBritish Journal of Cancer, 2007